FDA Stops EUA Review of SQI COVID-19 Severity Triage Test
The FDA cites de-prioritization due to high volume of EUA reviews and recommends a different approval pathway for the SQI COVID-19 RALI-Dx IL-6 Severity Triage Test.
Read MorePosted by Melanie Hamilton-Basich | Jul 26, 2021 | Covid 19 |
The FDA cites de-prioritization due to high volume of EUA reviews and recommends a different approval pathway for the SQI COVID-19 RALI-Dx IL-6 Severity Triage Test.
Read MorePosted by Melanie Hamilton-Basich | Jul 26, 2021 | Covid 19 |
Medical groups including the AMA are calling on healthcare employers to make COVID-19 vaccination mandatory for those who work for them, reports the New York Times, which could affect those who work at laboratories in healthcare facilities.
Read MorePosted by Chris Wolski | Jul 23, 2021 | Covid 19, Rapid Assays |
BioIQ has been approved to facilitate COVID-19 testing for athletes and staff entering Japan for the Tokyo Olympics.
Read MorePosted by Chris Wolski | Jul 22, 2021 | Covid 19, Immunoassay Reagents & test Kits, Rapid Assays |
A recent study shows that a new protocol for coronavirus testing can increase clinical labs’ testing capacity without sacrificing accuracy.
Read MorePosted by Melanie Hamilton-Basich | Jul 21, 2021 | Covid 19 |
Eurofins Viracor’s inSight T Cell Immunity test delivers an understanding of a patient’s response to viral antigens, providing critical insight to aid in treatment decisions.
Read More